Intranasal Midazolam Dosing for Children
For intranasal midazolam in children, use 0.4-0.5 mg/kg (maximum 10 mg) for procedural sedation, with onset at 8-15 minutes and duration of 25-60 minutes.
Initial Dosing by Indication
Procedural Sedation (Laceration Repair, Imaging)
- Recommended dose: 0.4-0.5 mg/kg intranasal 1, 2
- Lower doses (0.2-0.3 mg/kg) result in inadequate sedation in 60-73% of cases 2, 3
- Maximum single dose: 10 mg (though not systematically studied) 4
- Onset: 8-15 minutes 5
- Duration: 25-40 minutes at lower doses, up to 60 minutes at 0.5 mg/kg 5
Preoperative Anxiolysis
- Dose: 0.3 mg/kg intranasal 6
- Achieves adequate sedation in 70-76% at 10-20 minutes 6
- Alternative: 0.25 mg/kg intranasal (comparable to 0.5 mg/kg oral) 7
Seizure Management
- IM route preferred for seizures: 0.2 mg/kg (maximum 6 mg per dose) 8
- May repeat every 10-15 minutes 8
- Note: Lorazepam typically preferred for initial IV treatment of status epilepticus 8
Age-Specific Considerations
Children <6 months:
- Limited data available; dosing unclear 4
- Particularly vulnerable to airway obstruction and hypoventilation
- Requires careful titration with small increments and close monitoring 4
Children 6 months-7 years:
- Standard intranasal dosing applies (0.4-0.5 mg/kg) 1
- Most evidence supports this age range for intranasal route
Maximum Doses and Repeat Dosing
- Single dose maximum: 10 mg 4
- Rescue dosing: If inadequate sedation at 15-20 minutes, consider additional sedation rather than repeat midazolam 3
- High-dose INM (0.5 mg/kg) reduces need for rescue sedation from 28% to 7.4% compared to low-dose (0.2 mg/kg) 3
Critical Safety Monitoring
Required monitoring includes:
- Continuous oxygen saturation monitoring 8, 9
- Respiratory rate and effort 4
- Blood pressure in hemodynamically compromised patients 4
- Airway patency assessment 9
Be prepared to provide:
- Respiratory support equipment immediately available 8, 9
- Flumazenil 0.01 mg/kg for reversal of life-threatening respiratory depression 8
- Note: Flumazenil will reverse anticonvulsant effects if used for seizures 8
Contraindications and Precautions
Relative contraindications:
- Baseline hypoxia 9
- Pulmonary hypertension 10
- Uncorrected bleeding diathesis 10
- Age <6 months (use extreme caution) 4
Dose reduction required for:
- Concurrent opioid administration (reduce both agents) 4
- Debilitated or high-risk patients 4
- Hepatic or renal impairment 4
Common Pitfalls
Underdosing is the most common error: Studies consistently show 0.2-0.3 mg/kg results in treatment failure rates of 20-60% 2, 6, 3. Start with 0.4-0.5 mg/kg to avoid inadequate sedation and the need for rescue medications.
Nasal irritation: Occurs in 36% of patients with intranasal administration 7. This is transient and does not require intervention but may cause brief distress.
Timing errors: Peak effect occurs at 8-15 minutes 5. Do not assume failure before 15-20 minutes have elapsed. Premature rescue dosing increases risk of oversedation.
Respiratory depression risk: Significantly increased when combined with opioids or other CNS depressants 8, 4. If co-administering, reduce initial doses of both agents and monitor more intensively.
Paradoxical agitation: May occur, especially in younger children 8. This is not treatment failure requiring more midazolam; consider alternative sedation strategy.